专题：Hemophilia Treatment and Research

This cluster of papers focuses on the management and treatment of hemophilia, including prophylaxis, inhibitors, gene therapy, and the impact on joint health. It covers a wide range of topics such as recombinant factor VIII, factor IX, and the safety and efficacy of various treatment strategies.
最新文献
Possible Liposomal Amphotericin B-Triggered Intracerebral Hemorrhage in Kala-Azar with Hemophagocytic Lymphohistiocytosis: A Case Study

article Full Text OpenAlex

Usefulness of Global Coagulation Tests, Thrombin Generation and Viscoelastic Tests for Assessing the Bleeding Phenotype in Rare Coagulation Factor Deficiencies

review Full Text OpenAlex

Overview on Rare Congenital Bleeding Disorders and Epidemiological Data from the German Haemophilia Registry (DHR) and a Survey in Germany, Austria, and Switzerland

review Full Text OpenAlex

Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B

article Full Text OpenAlex

Association of bullous pemphigoid with acquired hemophilia A: a case report

article Full Text OpenAlex

Concurrent congenital hemophilia B and acquired hemophilia A: a unique case report

article Full Text OpenAlex

Economic and Humanistic Burden of Moderate and Severe Hemophilia A and B in Spain: Real-World Evidence Insights from the CHESS II Study

article Full Text OpenAlex

Bone and joint health in children with severe hemophilia A: A single-center, prospective case-control study from North India

article Full Text OpenAlex

Inhibitor eradication and treatment for acquired hemophilia A

article Full Text OpenAlex

30‐sit‐to‐stand power is a better tool than isometric knee extensor strength to detect motor impairment in people with haemophilic arthropathy

article Full Text OpenAlex

近5年高被引文献
ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease

article Full Text OpenAlex 468 FWCI64.60833701

Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A

article Full Text OpenAlex 337 FWCI76.12215577

Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B

article Full Text OpenAlex 286 FWCI111.97078841

Haemophilia

review Full Text OpenAlex 270 FWCI36.57425974

Hemophilic arthropathy: Current knowledge and future perspectives

review Full Text OpenAlex 239 FWCI31.00457552

Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A

article Full Text OpenAlex 219 FWCI33.78941763

Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A

article Full Text OpenAlex 164 FWCI63.98330766

Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A

article Full Text OpenAlex 149 FWCI57.35089162

A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH

article Full Text OpenAlex 139 FWCI19.49389479

Phase 1–2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B

article Full Text OpenAlex 136 FWCI34.65826698